A Multiple-Center, Randomized, Double-blind, Multiple-Dose, Placebo-Controlled, Parallel-Group Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO0640796 (Oseltamivir) and Its Carboxylate Metabolite, RO0640802, Following Intravenous Administrations in Healthy Subjects
Latest Information Update: 04 Jul 2016
At a glance
- Drugs Oseltamivir (Primary)
- Indications Influenza virus infections
- Focus Pharmacokinetics
- Sponsors Roche
- 10 Jul 2012 New trial record